GPD1L and melanoma: showed that T cell clones that recognise the cancer antigen protein glycerol-3-phosphate dehydrogenase 1-like (GPD1-L) and cross-react with epitopes derived from the tail tape measure protein (TMP) of an Enterococcus hirae (E. hirae) bacteriophage, could be detected in melanoma patients.